Advanced Filters
noise

Hepatitis A Vaccine Clinical Trials

A listing of Hepatitis A Vaccine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 223 clinical trials
F Feng Sun, doctor

Real-world Study Optimizing Nucleotide-analogues

The goal of this multicenter, observational, prospective study is to observe and compare different anti-viral treatment strategies in a real-world cohort of patients with CHB managed in routine clinical settings in China. The main questions it aims to answer are: To evaluate the benefits of initiating first-line nucleos(t)ide analogue in …

18 - 80 years of age All Phase N/A
R Rui Huang, M.D., Ph.D.

"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu

Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide. Patients with chronic HBV infection are at an increased risk for developing hepatic cirrhosis, hepatocellular carcinoma and even death. Although some predictive factors of the outcome of chronic HBV infection were identified, more precisely determine the …

years of age All Phase N/A
Y Yongyin Li, Dr.

Immune Dynamics in the Natural History of Chronic HBV Infection

The purpose of this observational study is to follow up on chronic HBV-infected patients over a long period of time to understand the changes in the immune status as age increases and the natural history of chronic HBV infection progresses. The main questions it aims to answer are: Does the …

1 - 80 years of age All Phase N/A
M Matthias Cremer, MD

Swiss Autoimmune Hepatitis Cohort Study

Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.

years of age All Phase N/A
S Soo Aleman, MD, PhD

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients

The aim is to assess the efficacy and specific safety in an observational study of patients with Chronic hepatitis D (CHD) with prospective follow-up, with antiviral treatment of 2 mg Bulevirtide (BLV) +/- PEG-IFNα-2a and +/- NA given as part of the patient's routine medical care. Also, explorative endpoints of …

18 years of age All Phase N/A
M Meifang Han, professor

A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B

This is a prospective, multicentre observational study of Chronic Hepatitis B (CHB)in different clinical stages. We intend to compare the immune status of various types of CHB patients, and we propose to establish a staging and grading criteria for the immune exhaustion status of patients with CHB.

18 - 50 years of age All Phase N/A
A Angel Chim

HDV Screening Study

This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.

18 years of age All Phase N/A
F Fahong Li

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

The goal of this observational study is to learn about the HBsAg reversion rate at 48 weeks off treatment in HBsAg-negative patients by HBsAg NEXT assay which has improved sensitivity compared to current ARCHITECT HBsAg Assay. The main question it aims to answer is: What's the HBsAg reversion rate at …

18 - 65 years of age All Phase N/A
L Lasha Abesadze

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Implementation and evaluation of a distribution program for low dead-space syringes/needles (LDSS/N) in Armenia, Georgia, and Tanzania, Egypt, Nigeria, Vietnam, India, Ukraine, and South Africa. This study aims to generate evidence on best practice LDSS/N distribution programs which will enhance acceptability and sustain high levels of LDSS/N uptake. People who …

18 years of age All Phase N/A
Y Yiqi Yu, doctor

Real World Study of Chronic Viral Hepatitis

This study is aimed to collect and analyze clinical data of patients with chronic viral hepatitis in the real world, to investigate the long-term outcome of these patients and to optimize treatment options based on these data.

18 - 75 years of age All Phase N/A

Simplify language using AI